Stockreport

Radiopharm Theranostics Shares RAD101 Phase IIb Update: 90% Hit Primary Endpoint in Brain Mets Study [Yahoo! Finance]

Radiopharm Theranostics Limited - American Depositary Shares  (RADX) 
PDF endpoint for RAD101 imaging of suspected post-treatment brain metastases; enrollment is nearly complete and official study results are expected in May–June with planned [Read more]